D-ser2-oxyntomodulin
D-ser2-oxyntomodulin has been studied in 1 paper since 2022: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Sep 3, 2022: “Importance of Bmal1 in Alzheimer's disease and associated aging-related diseases: Mechanisms and interventions”.
1 paper studies itUpdated